US Medical Radiopharmaceuticals Market

US Medical Radiopharmaceuticals Market

New Growth Opportunities Emerge in a Strenuous Market

RELEASE DATE
26-Sep-2013
REGION
North America
Research Code: NC7B-01-00-00-00
SKU: MX00050-NA-MR_17562

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
MX00050-NA-MR_17562

$4,950.00

$3,712.50 save 25 %

DownloadLink

Pay by invoice

ENQUIRE NOW

Description

This research service pertains to the US market for medical radiopharmaceuticals. A thorough market sizing and forecasting model of market revenue, procedure volumes, and average pricing is included, along with analyses of market trends, drivers and restraints, and the reimbursement and the competitive environments at the total level as well as within each segment. The three market segments considered are diagnostic SPECT radiopharmaceuticals, diagnostic PET radiopharmaceuticals and therapeutic radiopharmaceuticals. The base year of the study is 2012 and the forecast period extends seven years through 2019.

Table of Contents

Executive Summary

Executive Summary (continued)

Executive Summary—Market Engineering Measurements

Executive Summary—Market Engineering Measurements (continued)

Executive Summary—CEO’s Perspective

Market Overview—Definitions

Market Overview—Definitions (continued)

Market Overview—Introduction

Market Overview—Distribution Structure and Clinical Applications

Distribution Structure and Clinical Applications Discussion

Market Overview—Scope of Study

Market Overview—Key Questions This Study Will Answer

Market Overview—Segmentation

Market Overview—Segmentation (continued)

Drivers and Restraints

Drivers—Impact and Duration

Drivers Explained

Drivers Explained (continued)

Drivers Explained (continued)

Drivers Explained (continued)

Drivers Explained (continued)

Restraints—Impact and Duration

Restraints Explained

Restraints Explained (continued)

Restraints Explained (continued)

Restraints Explained (continued)

Restraints Explained (continued)

Restraints Explained (continued)

Total Medical Radiopharmaceuticals Market— Introduction

Total Medical Radiopharmaceuticals Market— Introduction (continued)

Market Engineering Measurements

Market Engineering Measurements (continued)

Forecast Assumptions

Total Medical Radiopharmaceuticals Market—Revenue Forecast

Revenue Forecast Discussion

Revenue Forecast Discussion (continued)

Total Medical Radiopharmaceuticals Market—Revenue Forecast by Segment

Revenue Forecast by Segment Discussion

Radiopharmaceutical Reimbursement—Introduction

Reimbursement of Procedures Involving Use of Radiopharmaceuticals

Reimbursement of Procedures Involving Use of Radiopharmaceuticals (continued)

Reimbursement of Procedures Involving Use of Radiopharmaceuticals (continued)

Reimbursed Radiopharmaceuticals Billing Codes

Reimbursed Radiopharmaceuticals Billing Codes (continued)

Reimbursed Radiopharmaceuticals Billing Codes (continued)

Reimbursed Radiopharmaceuticals Billing Codes (continued)

Key Industry Participants and Main Product Lines

Competitive Analysis—Market Share

Market Share Analysis

Radiopharmacy Facility Landscape

Competitive Environment

Competitive Factors and Assessment

Diagnostic SPECT Radiopharmaceuticals Segment Breakdown

Diagnostic SPECT Radiopharmaceuticals Segment—Market Engineering Measurements

Diagnostic SPECT Radiopharmaceuticals Segment—Revenue Forecast

Revenue Forecast Discussion

Revenue Forecast Discussion (continued)

Diagnostic SPECT Radiopharmaceuticals Segment—Procedure Volume Forecast

Procedure Volume Forecast Discussion

Diagnostic SPECT Radiopharmaceuticals Segment—Pricing Trends and Forecast

Pricing Trends and Forecast Discussion

Competitive Analysis—Market Share

Market Share Analysis

Diagnostic PET Radiopharmaceuticals Segment Breakdown

Diagnostic PET Radiopharmaceuticals Segment—Market Engineering Measurements

Diagnostic PET Radiopharmaceuticals Segment—Revenue Forecast

Revenue Forecast Discussion

Diagnostic PET Radiopharmaceuticals Segment—Procedure Volume Forecast

Procedure Volume Forecast Discussion

Procedure Volume Forecast Discussion (continued)

Diagnostic PET Radiopharmaceuticals Segment—Pricing Trends and Forecast

Pricing Trends and Forecast Discussion

Competitive Analysis—Market Share

Market Share Analysis

Radioimmunotherapy Agents Segment—Background

Radioimmunotherapy Agents Segment—Introduction

Radioimmunotherapy Agents Segment Breakdown

Radioimmunotherapy Agents Segment—Market Engineering Measurements

Radioimmunotherapy Agents Segment—Revenue Forecast

Revenue Forecast Discussion

Revenue Forecast Discussion (continued)

Revenue Forecast Discussion (continued)

Revenue Forecast Discussion (continued)

Revenue Forecast Discussion (continued)

The Last Word—Three Big Predictions

Legal Disclaimer

Market Engineering Methodology

Learn More—Next Steps

Related Research
This research service pertains to the US market for medical radiopharmaceuticals. A thorough market sizing and forecasting model of market revenue, procedure volumes, and average pricing is included, along with analyses of market trends, drivers and restraints, and the reimbursement and the competitive environments at the total level as well as within each segment. The three market segments considered are diagnostic SPECT radiopharmaceuticals, diagnostic PET radiopharmaceuticals and therapeutic radiopharmaceuticals. The base year of the study is 2012 and the forecast period extends seven years through 2019.
More Information
No Index No
Podcast No
Author Nadim Daher
Industries Healthcare
WIP Number NC7B-01-00-00-00
Is Prebook No